Physician profile
Ramona Rule
NPI 1437372752
$967.17
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $572 · 2022: $335 · 2023: $59.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $337.60 | 2021-2022 | |
| Amgen INC. | $88.19 | 2021-2022 | |
| Organon LLC | $75.79 | 2021-2022 | |
| Evofem Biosciences, INC. | $75.22 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $66.62 | 2021-2022 | |
| Boston Scientific Corporation | $38.78 | 2023 | Spaceoar Vue System - 10ml |
| Therapeuticsmd, INC. | $36.92 | 2021 | |
| Scynexis, INC. | $28.93 | 2022 | |
| Pfizer INC. | $28.81 | 2021-2022 | |
| Sage Therapeutics, LLC | $24.21 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.57 | 2021 | |
| Coopersurgical, INC. | $23.30 | 2021 | |
| Hologic Sales and Service, LLC | $22.32 | 2022 | |
| Medtronic, INC. | $21.14 | 2023 | Truclear |
| Mylan Pharmaceuticals INC. | $20.57 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $20.27 | 2022 | |
| Agile Therapeutics, INC. | $17.48 | 2021 | |
| Medicem INC. | $17.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramona Rule listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.